Rinvoq

Fierce Pharma

AbbVie will continue to pursue external innovation for long-term

Amid reports that AbbVie is angling for a $1B buyout of neuroscience specialist Gilgamesh, the company revealed booming sales of Skyrizi and Rinvoq.

Kevin Dunleavy Jul 31, 2025 11:44am

AbbVie

AbbVie coughs up nearly $50M for Cugene's autoimmune med

May 16, 2022 10:05am